Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer

Frontiers in Bioscience

Volumn 16, Issue 3, 2011, Pages 980-996

  Bishayee, Anupam ^a   Ahmed, Shamima ^a   Brankov, Nikoleta ^a   Perloff, Marjorie ^b  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Breast cancer; Chemoprevention; Review; Treatment; Triterpenoids; Tumor cells

Indexed keywords

ANIMALIA;

ANTINEOPLASTIC AGENT; CUCURBITANE; DRUG DERIVATIVE; FRIEDELANE; GLYCOSIDE; LUPANE; OLEANANE; OLEANOLIC ACID; TRITERPENE; URSOLIC ACID;

ANIMAL; BREAST TUMOR; CHEMISTRY; CHEMOPROPHYLAXIS; HUMAN; MOUSE; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CHEMOPREVENTION; GLYCOSIDES; HUMANS; MICE; OLEANOLIC ACID; TRITERPENES;

EID: 79955034094     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3730     Document Type: Review

References (113)

1. J. Baselga and J. Mendelsohn: The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res Treat 29, 127-138 (1994) (Pubitemid 24104844)
2. V.C. Jordan: SERMs: meeting the promise of multifunctional medicines. J Natl Cancer Inst 99, 350-356 ( 2007) (Pubitemid 47078725)
3. American Cancer Society, Breast Cancer Facts and Figures 2009-2010. Atlanta: American Cancer Society (2009)
4. A. Stang and C. Thomssen: Decline in breast cancer incidence in the United States: what about male breast cancer? Breast Cancer Res Treat 112, 595-596 (2008)
5. V.G. Vogel: Chemoprevention strategies. Curr Treat Options Oncol 8, 74-88 (2007)
6. S. Sutherland, A. Sutherland, D. Miles, S Chan, A. Wardley, N. Davidson, R. Bhatti, M. Shehata, H. Nouras, T. Camburn, and S.R.D. Johnston: Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases - the UK experience. Br J cancer 102, 995-1002 (2010)
7. J. Chien and H. S. Rugo: The cardiac safety of trastuzumab in the treatment of breast cancer. Expert Opin Drug Saf 2, 335-346 (2010)
8. J. Bange, E. Zwick, and A. Ullrich: Molecular targets for breast cancer therapy and prevention. Nat Med 7, 548-552 (2001) (Pubitemid 32448320)
9. J. S. Wong and J. R. Harris: Importance of local tumor control in breast cancer. Lancet Oncol 2, 11-17 (2001) (Pubitemid 33585912)
10. J. Loncaster and D. Dodwell: Adjuvant radiotherapy in breast cancer. Are there factors that allow selection of patients who do not require adjuvant radiotherapy following breast-conserving surgery for breast cancer? Minerva Med 93, 101-107 (2002) (Pubitemid 34662954)
11. M.B. Sporn and N. Suh: Chemoprevention of cancer. Carcinogenesis 21, 525-530 (2000) (Pubitemid 30137938)
12. V.C. Jordan: Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nature 7, 46-53 (2007) (Pubitemid 46020846)
13. A.B. Castrellon and S. Glüch: Chemoprevention of breast cancer. Expert Rev Anticancer Ther 8, 443-452 (2008) (Pubitemid 351836291)
14. X. Zhao, L. Li, and Z. Wang: Chemoprevention of breast cancer: current status and future prospects. Front Biosci 11, 2249-2256 (2006) (Pubitemid 43822556)
15. M.-H. Pan and C.-T. Ho: Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev 37, 2558-2574 (2008)
16. R. Naithani, L. C. Huma, R. M. Moriarty, D. L. McCormick, and R.G. Mehta: Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials. Curr Med Chem 15, 1044-1071 (2008) (Pubitemid 352005717)
17. A. Bishayee: Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res 2, 409-418 (2009)
18. A. Bishayee, A. Waghray, M.A. Patel, and M. Chatterjee: Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence. Cancer Lett 294, 1-12 (2010)
19. L.G. Korkina, C. De Luca, V.A. Kostyuk, and S. Pastore: Plant polyphenols and tumors: from mechanisms to therapies, prevention, and protection against toxicity of anti-cancer treatments. Curr Med Chem 16, 3943-3965 (2009)
20. T. Dennis, M. Fanous, and S. Mouse: Natural products for chemopreventive and adjunctive therapy in oncologic disease. Nutr Cancer 61, 587-597 (2009)
21. T. Rabi and A. Bishayee: Terpenoids and breast cancer prevention. Breast Cancer Res Treat 115, 223-239 (2009)
22. F. Rohdich, A. Bacher, and W. Eisenreich: Isoprenoid biosynthetic pathways as anti-infective drug targets. Biochem Soc Trans 33, 785-791 (2005) (Pubitemid 41160864)
23. S.T. Withers and J.D. Keasling: Biosynthesis and engineering of isoprenoid small molecules. Appl Microbiol Biotechnol 73, 980-990 (2007) (Pubitemid 44974305)
24. W.N. Setzer and M.C. Setzer: Plant-derived triterpenoids as potential antineoplastic agents. Mini Rev Med Chem 3, 540-556 (2003)
25. K.T. Liby, M.M. Yore, and M.B. Sporn: Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer 7, 357-369 (2007) (Pubitemid 46652485)
26. M.N. Laszczyk: Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med 75, 1549-1560 (2009)
27. A. Petronelli, G. Pannitteri, and U. Testa: Triterpenoids as new promising anticancer drugs. Anti-Cancer Drugs 20, 880-892 (2009)
28. Z. Ovensná, A. Vachalková, K. Horváthová, and D. Táthová: Pentacyclic triterpenoic acids: new chemoprotective compounds. Neoplasma 51, 327-333 (2004)
29. C.C. Neto: Cranberry and its phytochemicals: a review in in vitro anticancer studies. J Nutr 137, 1865-1935 (2007)
30. C. Gerhauser: Cancer chemopreventive potential of apples, apple juice, and apple components. Planta Med 74, 1608-1624 (2008)
31. D.R. Phillips, J.M. Rasbery, B. Bartel, and S.P. Masuda: Biosynthetic diversity in plant triterpene cyclization. Curr Opin Plant Biol 9, 305-314 (2006)
32. F.B. Mullauer, J.H. Kessler, and J.P. Madema: Betulinic acid, a natural compound with potent anticancer effects. Anti-Cancer Drugs 21, 215-227 (2010)
33. The Wealth of India Raw Materials, Vol. 9. New Delhi: Publications and Information Directorate, Council of Scientific and Industrial Research (1948-1976)
34. K.C. Huang, The Pharmacology of Chinese Herbs, Tokyo: CRC Press (1993)
35. N. Sultana and A. Ata: Oleanolic acid and related derivatives as medicinally important compounds. J Enzyme Inhibition Med Chem 23, 739-756 (2008)
36. B.A. Shah, G.N. Qazi, and S.C. Taneja: Boswellic acids: a group of medicinally important compounds. Nat Prod Rep 26, 72-89 (2009)
37. J.C. Chen, M.H. Chiu, R.L. Nie, G.A. Cordell, and S.X. Qin: Cucurbitacins and cucurbitane glycosides structures and biological activities. Nat Prod Rep 22, 386-399 (2005)
38. J. Turkson and R. Jove: STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19, 6613-6626 (2000) (Pubitemid 32197700)
39. T. Bowman, R. Garcia, J. Turkson, and R. Jove: STATs in oncogenesis. Oncogene 19, 2474-2488 (2000) (Pubitemid 30339203)
40. M.A. Blaskovich, J. Sun, A. Cantor, J. Turkson, R. Jove, and S.M. Sebti: Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 63, 1270-1279 (2003) (Pubitemid 36348705)
41. J. Sun, M.A. Blaskovich, R. Jove, S.K. Livingston, D. Coppola, and S.M. Sebti: Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24, 3236-3245 (2005) (Pubitemid 40695105)
42. N. Rodriguez, Y. Vasquez, A.A. Hussain, P.D. Coley, P.N. Solis, and M.P. Gupta: Cytotoxic cucurbitacin constituents from Sloanea zuliaensis. J Natl Prod 66, 1515-1516 (2003) (Pubitemid 37490408)
43. B. Jayaprakasam, N.P. Seeram, and M.G. Nair: Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett 189, 11-16 (2003)
44. D. Olmedo, N. Rodriguez, Y. Vasquez, P.N. Solis, J.L. Lopez-Perez, A. San Feliciano, and M.P. Gupta: A new coumarin from the fruits of Coutarea hexandra. Nat Prod Res 21, 625-331 (2007)
45. L. Yang, S. Wu, Q. Zhang, F. Liu, and P. Wu: 23-24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and mitochondria-dependent apoptosis in human breast cancer cells (Bcap37). Cancer Lett 256, 267-278 (2007) (Pubitemid 47418353)
46. N. Wakimoto, D. Yin, J. O'Kelley, T. Haritunians, J. Said, H. Xing, and H. Phillip Koeffler: Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo. Cancer Sci 99, 1793-1797 (2008)
47. S. Kongtun, W. Jiratchariyakul, T. Kummalue, P. Tanariya, S. Kunnachak, and A. Wilhelm Frahm: Cytotoxic properties of root extract and fruit juice of Trichosanthes cucurbitacinumerina. Planta Med 75, 839-842 (2009)
48. C. Ramalhete, T.A. Mansoor, S. Mulhovo, J. Molnár, and M.-J. U. Ferreira: Cucurbitane-type triterpenoids from the African plant Momordica balsamina. J Natl Prod 72, 2009-2013 (2009)
49. J. Phongmaykin, T. Kumamoto, T. Ishikawa, R. Suttisri, and E. Saifah: A new sesquiterpene and other terpenoid constituents of Chisocheton penduliflorus. Arch Pharm Res 31: 21-27 (2008)
50. Z.T. Tsai and S.L. Liaw, The Use and the Effect of Ganoderma. Taichung: San Yun Press (1985)
51. C.-T. Yeh, Y. K. Rao, C.-J. Yao, C.-F. Yeh, C.-H. Li, S.-E. Chuang, J.H.T. Luong, G.-M. Lai, and Y.-M. Tzeng: Cytotoxic triterpenes from Antrodia camphorate and their mode of action in HT-29 human colon cancer cells. Cancer Lett 285, 73-79 (2009)
52. W.N. Setzer, M.T. Holland, C.A. Bozeman, G.F. Rozmus, M.C. Setzer, D.M. Moriarity, S. Reeb, B. Vogler, R.B. Bates, and W.A. Haber: Isolation and frontier molecular orbital investigation of bioactive quinine-methide triterpenoids from the bark of Salacia petenesis. Planta Med 67, 65-69 (2001) (Pubitemid 32199948)
53. F.-R. Chang, K.-I. Hayashi, I.-H. Chen, C.C. Liaw, K.F. Bastow, Y. Nakanishi, H. Nozaki, G.M. Cragg, Y.-C. Wu, and K.-H. Lee: Antitumor agents. 228. Five new agarofurans, reissantins A-E, and cytotoxic principles from Reissantia buchananii. J Natl Prod 66, 1416-1420 (2003) (Pubitemid 37490387)
54. C.-C. Wu, M.-L. Chan, W.-Y. Chen, C.-Y. Tsai, F.-R. Chang, and Y.-C. Wu: Pristimerin induces caspase-dependent apoptosis in MDA-MB-231 cells via direct effects on mitochondria. Mol Cancer Ther 4, 1277-1285 (2005) (Pubitemid 41149576)
55. A.I. Idris, H. Libouban, H. Nyangoga, E. Landao-Bassonga, D. Chappard, and S.H. Ralston: Pharmacologic inhibitors of I?β kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo. Mol Cancer Ther 8, 2339-2347 (2009)
56. B. Sung, B. Park, V.R. Yadav, and B.B. Aggarwal: Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the downregulation of cell survival proteins and upregulation of death receptors. J Biol Chem 285, 11498-11507 (2010)
57. G.C.L. Ee, C.K. Lim, A. Rahmat, and H.L. Lee: Cytoxic activities of chemical constituents from Mesua daphnifolia. Trop Biomed 22, 99-102 (2005)
58. L. Zeng, Z.-M. Gu, C.-J. Chang, K.V. Wood, and J. L. McLaughlin: Meliavolkenin, a new bioactive triterpenoid from Melia volkensii. Bioorg Med Chem 3, 383-390 (1995)
59. L.L. Rogers, L. Zeng, J.F. Kozlowski, H. Shimada, F.Q. Alali, H.A. Johnson, and J.L. McLaughlin: New bioactive triterpenoids from Melia volkensii. J Natl Prod 61, 64-70 (1998) (Pubitemid 28086976)
60. E. Pisha, H. Chai, I.S. Lee, T.E. Chagwedera, N.R. Farnsworth, G.A. Cordell, C.W. Beecher, H.H. Fong, A.D. Kinghorn, D.M. Brown, M.C. Wani, M.E. Hall, T.J. Hieken, T.K. Das Gupta, and J.M. Pezzuto: Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1, 1046-1051 (1995)
61. W.N. Setzer, M.C. Setzer, R.B. Bates, and B.R. Jackes: Biologically active triterpenoids of Syncarpia glomulifera extract from Paluma, North Queensland, Australia. Planta Med 66, 176-177 (2000) (Pubitemid 30164364)
62. V. Amico, V. Barresi, D. Condorelli, C. Spatafora, and C. Tringali: Antiproliferative terpenoids from almond hulls (Prunus dulcis): identification and structure-activity relationships. J Agric Food Chem 54, 810-814 (2006) (Pubitemid 43274119)
63. W. Rzeski, A. Stepulak, M. Szymański, M. Sifringer, J. Kaczor, K Wejksza, B. Zdzisińska, and M. Kandefer-Szerszen: Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn-Schmeiedeberg's Acrh Pharmacol 374, 11-20 (2006)
64. S. Basu, R. Ma, P.J. Boyle, B. Mikulla, M. Bradley, B. Smith, M. Basu, and S. Banerjee: Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKB3 cells with: cis-platin, tamoxifen, melphalan, betulic acid, L-PDMP, L-PPMP, and GD3 ganglioside. Glycoconj J 20, 563-577 (2004) (Pubitemid 41406513)
65. J.H. Kessler, F.B. Mallauer, G.M. de Roo, and J.P. Medema: Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types. Cancer Lett 251, 132-145 (2007) (Pubitemid 46589768)
66. W. Rzeski, A. Stepulak, M. Szymański, M. Juszczak, A. Grabarska, M. Sifringer, J. Kaczor, and M. Kandefer-Szerszeń: Betulin elicits anti-cancer effects in tumor primary cultures and cell lines in vitro. Basic Clin Pharmacol Toxicol 105, 425-432 (2009)
67. E. Lambertini, I. Lampronti, L. Penolazzi, M.T. Khan, A. Ather, G. Giorgi, R. Gambari, and R. Piva: Expression of estrogen receptor alpha gene in breast cancer cells treated with transcription factor decoy is modulated by Bangladeshi natural plant extracts. Oncol Res 14, 69-79 (2005) (Pubitemid 40825918)
68. Y. Deng, T.-Y. Jiang, S. Sheng, M. Tianasoa-Ramamonjy, and J.K. Snyder: Remangilones A - C, new cytotoxic triterpenes from Physena madagascariensis. J Natl Prod 62, 471-476 (1999) (Pubitemid 29165227)
69. B.-S. Yun, I.-J. Ryoo, I.-K. Lee, K.-H. Park, D.-H. Choung, K.-H. Han, and I.-D. Yoo: Two bioactive pentacyclic triterpene esters from the root bark of Hibiscus syriacus. J Natl Prod 62, 764-766 (1999) (Pubitemid 29259100)
70. H.-F. Hsu, J.-Y. Houng, C.-L. Chang, C.-C. Wu, F.-R. Chang, and Y.-C. Wu: Antioxidant activity, and DNA information of Glossogyne tenuifolia. J Agric Food Chem 53, 6117-6125 (2005) (Pubitemid 41126656)
71. N. Suh, Y. Wang, T. Honda, G. W. Gribble, E. Dmitrovsky, W. F. Hickey, R. A. Maue, A. E. Place, D. M. Porter, M.J. Spinella, C. R. Williams, G. Wu, A. J. Dannenberg, K. C. Flanders, J. J. Letterio, D.J. Mangelsdorf, C. F. Nathan, L. Nguyen, W. W. Porter, R. F. Ren, A. B. Roberts, N. S. Roche, K. Subbaramaiah, and M. B. Sporn: A novel synthetic oleanane triterpenoid, 2-cyano-3,12- dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-Inflammatory activity. Cancer Res 59, 336-341 (1999) (Pubitemid 29048864)
72. A. Murakami and H. Ohigashi: Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 121, 2357-2363 (2007) (Pubitemid 350022403)
73. J. K. Kundu and Y.-J. Surh: Inflammation: gearing the journey to cancer. Mutat Res 659, 15-30 (2008)
74. H. Lapillonne, M. Konopleva, T. Tsao, D. Gold, T. Mcqueen, R. L. Sutherland, T. Madden, and M. Andreeff: Activation of peroxisome proliferators-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxoleana-1,9-dien-28oic acid induces growth arrest and apoptosis in breast cancer cells. Cancer Res 63, 5926-5939 (2003) (Pubitemid 37187494)
75. M. Konopleva, W. Zhang, Y. Shi, T. McQueen, T. Tsao, M. Abdelrahim, M. F. Munsell, M. Johansen, D. Yu, M. Hung, and M. Andreeff: Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-over expressing breast cancer cells. Mol Cancer Ther 5, 317-328 (2006)
76. E. Place, N. Suh, C. R. Williams, R. Risingsong, T. Honda, Y. Honda, G. W. Gribble, L. M. Leesnitzer, J. B. Stimmel, T. M. Wilson, E. Rosen, and M. B. Sporn: The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. Clin Cancer Res 9, 2798-2806 (2003) (Pubitemid 36842126)
77. M.L. Hyer, R. Croxton, M. Krajewska, S. Krajewski, C.L. Kress, M. Lu, N. Suh, M.B. Sporn, V.L. Cryns, J. Zapata, and J.C. Reed: Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosisinducing ligand to induce apoptosis of breast cancer cells. Cancer Res 65, 4799-4808 (2005) (Pubitemid 40740818)
78. T. Honda, T. Janosik, Y. Honda, J. Han, K.T. Liby, C.R. Williams, R.D. Couch, A.C. Anderson, M.B. Sporn, and G.W. Gribble: Design, synthesis and biological evaluation of biotin conjugates of 2-cyano-3,12-dioxooleana-1,9(11)- dien-28-oic acid for the isolation of the protein targets. J Med Chem 47, 4923-4932 (2004) (Pubitemid 39238267)
79. X. Ling, M. Konopleva, Z. Zeng, V. Ruvolo, L.C. Stephens, W. Schober, T. Mcqueen, M. Dietrich, T.L. Madden, and M. Andreeff: The novel triterpenoid C-28 methyl ester of 2-cyano-3,12-dioxolen-1,9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. Cancer Res 67, 4210-4218 (2007) (Pubitemid 46815067)
80. R. Ahmad, D. Raina, C. Meyer, and D. Kufe: Triterpenoid CDDO-methyl ester inhibits the Janusactivated kinase-1 (JAK1)→signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3. Cancer Res 68, 2920-2926 (2008) (Pubitemid 351556292)
81. Z. Duan, R.Y. Ames, M. Ryan, F.J. Hornicek, H. Mankin, and M.V. Seiden: CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells. Cancer Chemother Pharmacol 63, 681-689 (2009)
82. R.N. Chopra and I.C. Chopra, Glossary of Indian Medicinal Plants. New Delhi: Council of Scientific and Industrial Research (1965)
83. G.C. Prasad: Studies on cancer in Ayurveda and its management. J Res Ayurveda Siddha 8, 147-167 (1987)
84. T. Rabi, D. Karunagaran, M. Krishnan Nair, and V.N. Bhattathiri: Cytotoxic activity of amooranin and its derivatives. Phytother Res 16, S84-S86 (2002) (Pubitemid 34297489)
85. T. Rabi, C. Ramachandran, H. B. Fonseca, R. P. Nair, A. Alamo, S. J. Melnick, and E. Escalon: Novel drug amooranin induces apoptosis through caspase activity in human breast carcinoma cell lines. Breast Cancer Res Treat 80, 321-330 (2003) (Pubitemid 37046756)
86. T. Rabi, L. Wang, and S. Banerjee: Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Breast Cancer Res Treat 101, 27-36 (2007) (Pubitemid 47555335)
87. T. Rabi and S. Banerjee: Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cells. Mol Carcinog 47, 415-423 (2008) (Pubitemid 351822300)
88. I.O. Chávez, T.R. Apan, and M. Martínez-Vázquez: Cytotoxic activity and effect on nitric oxide production of tirucallane-type triterpenes. J Pharm Pharmacol 57, 1087-1091 (2005) (Pubitemid 41391767)
89. D. Es-Saady, A. Simon, C. Jayat-Vignoles, A.J. Chulia, and C. Delage: MCF-7 cell cycle arrested at G1 through ursolic acid, and increased reduction of tetrazolium salts. Anticancer Res 16, 481-486 (1996) (Pubitemid 26128512)
90. C.C. Neto, A.J. Vaisberg, B.-N. Zhou, D.G.I. Kingston, and G.B. Hammond: Cytotoxic triterpene acids from the Peruvian medicinal plant Polylepis racemosa. Planta Med 66, 483-484 (2000) (Pubitemid 30413517)
91. K. Subbaramaiah, P. Michaluart, M.B. Sporn, and A.J. Dannenberg: Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res 60, 2399-2404 (2000) (Pubitemid 30262429)
92. C. Martín-Cordero, M. Reyes, M. Jesus, and M.V.Toro: Cytotoxic triterpenoids from Erica andvalensis. Z. Naturforsch 56c, 45-48 (2001)
93. I. Lee, J. Lee, Y.H. Lee, and J. Leonard: Ursolic acidinduced changes in tumor growth, O2 consumption, and tumor interstitial fluid pressure. Anticancer Res 21, 2827-2834 (2001)
94. X. He and R.H. Liu: Cranberry phytochemicals: isolation, structure elucidation, and their antiproliferative and antioxidant activities. J Agric Food Chem 54, 7069-7074 (2006) (Pubitemid 44574265)
95. B.T. Murphy, S.L. MacKinnon, X. Yan, G.B. Hammond, A.J. Valisburg, and C.C. Neto: Identification of triterpene hydroxycinnamates with in vitro antitumor activity from whole cranberry fruit (Vaccinium macrocarpon). J Agric Food Chem 51, 3541-3545 (2003)
96. Y.-H. Chen, F.-R. Chang, C.-C. Wu, M.-H. Yen, C.-C. Liaw, H.-C. Huang, Y.-H. Kuo, and Y.-C. Wu: New cytotoxic 6-oxygenated 8,9-dihydrofurocoumarins, Hedyotiscone A - C, from Hedyotis biflora. Planta Med 72, 75-78 (2006) (Pubitemid 43241598)
97. X. He and R. H. Liu: Triterpenoids isolated from apple peels have potent antiproliferative activity and may be partially responsible for apple's anticancer activity. J Agric Food Chem 55, 4366-4370 (2007) (Pubitemid 46932631)
98. H. Yoon and R. H. Liu: Effect of 2α-hydroxyursolic acid on NF-?B activation induced by TNF-α in human breast cancer MCF-7 Cells. J Agric Food Chem 56, 8412-8417 (2008)
99. E. Kassi, T.G. Sourlingas, M. Spiliotaki, Z. Papouts, H. Pratsinis, and P. Moutsatsou: Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells. Cancer Invest 27, 723-733 (2009)
100. C.-T. Yeh, C.-H. Wu, and G.-C. Yen: Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling. Mol Nutr Food Res 54, 1-11 (2010)
101. J.S. Lee, J. Kim, B.Y. Kim, H.S. Lee, J.S. Ahn, and Y.S. Chang: Inhibition of phospholipase Cγ1 and cancer cell proliferation by triterpene esters from Uncaria rhynchophylla. J Natl Prod 63, 753-756 (2000) (Pubitemid 30452165)
102. H.-L. Hsu, P.L. Kuo, L.T. Lin, and C.C. Lin: Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. J Pharmacol Exp Ther 313, 333-344 (2005)
103. I. Smith-Kielland, J.M. Domish, K.E. Malterud, G. Hvistendahl, C. Rømming, O.C. Bøckman, P. Kolsaker, Y. Stenstrøm, and A. Nordal: Cytotoxic triterpenoids from the leaves of Euphorbia pulcherrima. Planta Med 62, 322-325 (1996)
104. M.S. Lavhale, S. Kumar, S.H. Misra, and S.L. Sitasawad: A novel triterpenoid isolated from the root bark of Ailanthus excelsa Roxb (tree of heaven), AECHL-1 as a potential anti-cancer agent. PLoS One 4, e5365 (2009)
105. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich, and W.L. McGuire: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182 (1987) (Pubitemid 17231334)
106. P.M. Ravdin, K.A. Cronin, N. Howlader, C.D. Berg, R.T. Chlebowski, E.J. Feuer, B.K. Edwards, and D.A. Berry: The decrease in breast-cancer incidence in 2003 in the United States. N Eng J Med 356, 1670-1674 (2007) (Pubitemid 46631679)
107. K. Liby, R. R. Song, D. B. Royce, C. R. Williams, M. M. Yore, T. Honda, G. W. Gribble, W. W. Lamph, N. Vannini, I. Sogno, A. Albini, and M. B. Sporn: Prevention and treatment of experimental estrogen receptor negative carcinogenesis by the synthetic triterpenoid CDDOmethyl ester and the rexinoid LG100268. Clin Cancer Res 14, 4556-4563 (2008)
108. T. Rabi: Antitumor activity of amooranin from Amoora rohituka stem bark. Currr Sci 70, 80-81 (1996) (Pubitemid 126419363)
109. K. Singletary, C. MacDonald, and M. Wallig: Inhibition of rosemary and carnosol of 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett 104, 43-48 (1996)
110. T. Sjöblom, S. Jones, L.D. Wood, D.W. Parsons, J. Lin, T.D. Barber, D. Mandelker, R.J. Leary, J. Ptak, N. Silliman, S. Szabo, P. Buckhaults, C. Farrell, P. Meeh, S.D. Markowitz, J. Willis, D. Dawson, J.K. Willson, A.F. Gazdar, J. Hartigan, L. Wu, C. Liu, G. Parmigiani, B.H. Park, K.E. Bachman, N. Papadopoulos, B. Vogelstein, K.W. Kinzler, and V.E. Velculescu: The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274 (2006) (Pubitemid 44571966)
111. M. Guo, S. Zhang, F. Song, D. Wang, Z. Liu, and S. Liu: Studies on the non-covalent complexes between oleanolic acid and cyclodextrins using electrospray ionization tandem mass spectroscopy. J Mass Spectrom 38, 723-731 (2003) (Pubitemid 36957814)
112. Y. Chen, J. Liu, X. Yang, X. Zhao, and H. Xu: Oleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effect. J Pharm Pharmacol 57, 259-264 (2005) (Pubitemid 40129096)
113. H.S. Kang, J.E. Park, Y.J. Lee, I.S. Chang, Y.I. Chung, and G. Tae: Preparation of liposomes containing oleanolic acid via micelle-to-vesicle transition. J Nanosci Nanotechnol 7, 3944-3948 (2007)